Inactive Instrument

Press Releases Fennec Pharmaceuticals Inc Other OTC

Equities

CA31447P1009

Real-time Estimate Cboe BZX Other stock markets 11:56:43 2024-05-13 am EDT			5-day change	1st Jan Change
9.895 ^USD	+39.76%		+3.66%	+10.97%

Apr. 23	Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing	MT
Apr. 19	Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024	May. 07	GL
Fennec Pharmaceuticals : Corporate Presentation March 2024	Mar. 30	PU
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update	Mar. 21	GL
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024	Mar. 19	GL
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024	Mar. 19	AQ
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand	Mar. 17	GL
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results	Feb. 29	GL
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results	Feb. 29	AQ
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin	Feb. 01	GL
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin	Feb. 01	AQ
Fennec Announces Incremental $5 Million Investment from Petrichor	Dec. 05	GL
Fennec Announces Incremental $5 Million Investment from Petrichor	Dec. 05	AQ
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences	Nov. 09	GL
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences	Nov. 09	AQ
Fennec Pharmaceuticals : Corporate Presentation November 2023	Nov. 06	PU
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update	Nov. 06	GL
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update	Nov. 06	AQ
Substitute Claims Upheld As Prior Art Is Inapplicable To Pharmaceutical Compositions	23-10-31	AQ
Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023	23-10-30	GL
Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023	23-10-30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Fennec Pharmaceuticals Inc Other OTC

Equities

CA31447P1009

Press Releases

Filters